415 related articles for article (PubMed ID: 33634031)
1. Game of Bones: How Myeloma Manipulates Its Microenvironment.
Moser-Katz T; Joseph NS; Dhodapkar MV; Lee KP; Boise LH
Front Oncol; 2020; 10():625199. PubMed ID: 33634031
[TBL] [Abstract][Full Text] [Related]
2. The Role of Tumor Microenvironment in Multiple Myeloma Development and Progression.
García-Ortiz A; Rodríguez-García Y; Encinas J; Maroto-Martín E; Castellano E; Teixidó J; Martínez-López J
Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33435306
[TBL] [Abstract][Full Text] [Related]
3. Cell autonomous and microenvironmental regulation of tumor progression in precursor states of multiple myeloma.
Manier S; Kawano Y; Bianchi G; Roccaro AM; Ghobrial IM
Curr Opin Hematol; 2016 Jul; 23(4):426-33. PubMed ID: 27101529
[TBL] [Abstract][Full Text] [Related]
4. The Role of Marrow Microenvironment in the Growth and Development of Malignant Plasma Cells in Multiple Myeloma.
Giannakoulas N; Ntanasis-Stathopoulos I; Terpos E
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33923357
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow microenvironment in myelomagenesis: its potential role in early diagnosis.
Balakumaran A; Robey PG; Fedarko N; Landgren O
Expert Rev Mol Diagn; 2010 May; 10(4):465-80. PubMed ID: 20465501
[TBL] [Abstract][Full Text] [Related]
6. Multiple Myeloma and the Immune Microenvironment.
Kawano Y; Roccaro AM; Ghobrial IM; Azzi J
Curr Cancer Drug Targets; 2017; 17(9):806-818. PubMed ID: 28201978
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis beyond the cancer clone(s) in multiple myeloma.
Bianchi G; Munshi NC
Blood; 2015 May; 125(20):3049-58. PubMed ID: 25838343
[TBL] [Abstract][Full Text] [Related]
8. Changing paradigms in diagnosis and treatment of monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM).
Ho M; Patel A; Goh CY; Moscvin M; Zhang L; Bianchi G
Leukemia; 2020 Dec; 34(12):3111-3125. PubMed ID: 33046818
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
Cesana C; Klersy C; Barbarano L; Nosari AM; Crugnola M; Pungolino E; Gargantini L; Granata S; Valentini M; Morra E
J Clin Oncol; 2002 Mar; 20(6):1625-34. PubMed ID: 11896113
[TBL] [Abstract][Full Text] [Related]
10. PD-L1/PD-1 Pattern of Expression Within the Bone Marrow Immune Microenvironment in Smoldering Myeloma and Active Multiple Myeloma Patients.
Costa F; Vescovini R; Marchica V; Storti P; Notarfranchi L; Dalla Palma B; Toscani D; Burroughs-Garcia J; Catarozzo MT; Sammarelli G; Giuliani N
Front Immunol; 2020; 11():613007. PubMed ID: 33488620
[TBL] [Abstract][Full Text] [Related]
11. Clonal Evolution of Multiple Myeloma-Clinical and Diagnostic Implications.
Salomon-Perzyński A; Jamroziak K; Głodkowska-Mrówka E
Diagnostics (Basel); 2021 Aug; 11(9):. PubMed ID: 34573876
[TBL] [Abstract][Full Text] [Related]
12. Multiple Myeloma: Molecular Pathogenesis and Disease Evolution.
Heider M; Nickel K; Högner M; Bassermann F
Oncol Res Treat; 2021; 44(12):672-681. PubMed ID: 34749378
[TBL] [Abstract][Full Text] [Related]
13. Molecular Impact of the Tumor Microenvironment on Multiple Myeloma Dissemination and Extramedullary Disease.
Forster S; Radpour R
Front Oncol; 2022; 12():941437. PubMed ID: 35847862
[TBL] [Abstract][Full Text] [Related]
14. The role of the bone microenvironment in regulating myeloma residual disease and treatment.
Dadzie TG; Green AC
Front Oncol; 2022; 12():999939. PubMed ID: 36072809
[TBL] [Abstract][Full Text] [Related]
15. Gene Expression Analysis of the Bone Marrow Microenvironment Reveals Distinct Immunotypes in Smoldering Multiple Myeloma Associated to Progression to Symptomatic Disease.
Isola I; Brasó-Maristany F; Moreno DF; Mena MP; Oliver-Calders A; Paré L; Rodríguez-Lobato LG; Martin-Antonio B; Cibeira MT; Bladé J; Rosiñol L; Prat A; Lozano E; Fernández de Larrea C
Front Immunol; 2021; 12():792609. PubMed ID: 34880879
[TBL] [Abstract][Full Text] [Related]
16. [Monoclonal gammopathy of undetermined significance and asymptomatic multiple myelom in the year 2014 ].
Adam Z; Krejčí M; Pour L; Sevčíková E; Křivanová A; Rehák Z; Koukalová R; Cermáková Z; Vaníček J; Sevčíková S
Vnitr Lek; 2014 Oct; 60(10):861-79. PubMed ID: 25382009
[TBL] [Abstract][Full Text] [Related]
17. DNA Barcoding Reveals Habitual Clonal Dominance of Myeloma Plasma Cells in the Bone Marrow Microenvironment.
Hewett DR; Vandyke K; Lawrence DM; Friend N; Noll JE; Geoghegan JM; Croucher PI; Zannettino ACW
Neoplasia; 2017 Dec; 19(12):972-981. PubMed ID: 29091798
[TBL] [Abstract][Full Text] [Related]
18. The multifunctional role of Notch signaling in multiple myeloma.
Sabol HM; Delgado-Calle J
J Cancer Metastasis Treat; 2021; 7():. PubMed ID: 34778567
[TBL] [Abstract][Full Text] [Related]
19. Micro-RNAs, New performers in multiple myeloma bone marrow microenvironment.
Abdi J; Qiu L; Chang H
Biomark Res; 2014; 2():10. PubMed ID: 24910775
[TBL] [Abstract][Full Text] [Related]
20. Role of Immunotherapy in Targeting the Bone Marrow Microenvironment in Multiple Myeloma: An Evolving Therapeutic Strategy.
Chung C
Pharmacotherapy; 2017 Jan; 37(1):129-143. PubMed ID: 27870103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
